Do you have an innovation or project that needs further development, but its practical feasibility and/or the (commercial) exploitation opportunities are still uncertain? Or are you working in the early stages of your startup?
Then you may be eligible for funding from the IXA-GO Impact Fund at the Vrije Universiteit Amsterdam (VU).
The IXA-GO Impact Fund is there to finance studies that determine conceptual, social, technical and/or economic feasibility and/or market opportunities.
Conditions
How does it work?
Procedure
IXA-GO Impact Fund in practice
Beyond Weather, a VU-spin-off, uses AI to make long term weather forecasts. Beyond Weather is now partnering with key stakeholders in the agricultural sector for product development that has the potential for necessary transitions in the agriculture industry. This product exploration is being made possible through the IXA-GO Impact Fund.
Sem Vijverberg, CTO of Beyond Weather, says: “I want to provide practical answers to problems that relate to climate change. Through working with stakeholders in agriculture we can develop tools that can help predict weather extremes and improve decision making processes.”
Amsterdam researchers have secured Biotech Booster funding for a total of six projects, that include a promising cancer treatment, a new diagnostic method for Alzheimer’s Disease, an implant helping blindness, lab innovation in biotechnology, and a nutritional intervention for mental health. The researchers will develop a solid business case for their innovations in the time […]
NewsPULSE Sport, a start-up from the Demonstrator Lab, has reached a significant milestone by winning the prestigious 14th Dutch Sports Innovation Award. The company’s flagship product, a cutting-edge athlete management system, integrates advanced software and artificial intelligence to revolutionize athlete health and performance monitoring. About the Innovation PULSE Sport’s athlete management system provides a holistic […]
NewsVU-AMS is on a mission to revolutionize how we understand and manage stress-related health issues. Now an official VU spin-off, there are big plans for clinical applications. Founder of VU AMS Martin Gevonden explains: “We offer researchers autonomic biomarkers that are valid, reliable and easy to use, without getting under the skin.” After thriving in […]
News